• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Emergency

Non-invasive ventilation linked with lower mortality in COPD exacerbations

byAnees DaudandJames Jiang
October 27, 2014
in Emergency, Pulmonology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. For patients admitted with chronic obstructive pulmonary disease (COPD) exacerbations requiring ventilatory support, non-invasive ventilation (NIV) was associated with a lower rate of mortality in the hospital as compared to invasive mechanical ventilation (IMV).

2. In addition, NIV was also associated with fewer days in the hospital, decreased cost, and decreased incidence of developing pneumonia while in the hospital compared with IMV.

Evidence Rating Level: 2 (Good)          

Study Rundown: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the US, and leads to about 800,000 hospitalizations per year in this country. The standard of care for management of COPD exacerbations includes supplemental oxygen, bronchodilators, systemic corticosteroids, and antibiotics. For those patients that require ventilation support, there has been some suggestion that non-invasive ventilation (NIV) may have better outcomes than invasive mechanical ventilation (IMV). This study used data from a large number of US hospital to help determine the outcomes for COPD patients who received NIV compared to IMV. The results of this study suggest that for patients admitted to the hospital with COPD exacerbations and who required ventilatory support, NIV was associated with a lower chance of mortality in the hospital compared to IMV. In addition, NIV was also associated with fewer days in the hospital, decreased cost, and decreased incidence of developing pneumonia while in the hospital compared with IMV.

A major strength of the study is the geographically varied hospitals from which the data were obtained, which makes the results more generalizable. The investigators also attempted to account for many of the demographic and comorbid condition differences to make the comparison between NIV and IMV outcomes more valid. However, since this was a retrospective study, causality is difficult to establish. Rather, it opens doors for future prospective studies. Lastly, relying on ICD9 codes, especially for comorbid conditions, often leads to unreliable data, which adds uncertainty to the results.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

High-frequency oscillatory ventilation may reduce the incidence of bronchopulmonary dysplasia in neonatal respiratory distress syndrome

Relevant Reading: Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure

In-Depth [retrospective cohort]: The data for this study was obtained from patient admissions from January 2008 to June 2011 at 420 hospitals that are enrolled in the database Premier Healthcare Informatics. The inclusion criteria were age greater than 40 years old, ICD9 codes for COPD exacerbation or acute respiratory failure in the setting of COPD, and patients who received mechanical ventilation within the first two days of hospitalization. The primary outcome of the study was in-hospital mortality. Important secondary outcomes included length of stay, cost, readmission, development of pneumonia in the hospital, and necessity to escalate from NIV to IMV if the former was initially chosen.

Amongst the almost 200,000 COPD exacerbation admissions during the study period, about 16.6% received ventilatory support, and 70.1% of those were initially treated with NIV. After adjusting for a number of patient, physician, and hospital characteristics, initial use of NIV was associated with decreased in-hospital mortality compared to IMV (OR, 0.54; 95% CI, 0.48-0.61). NIV was also associated with fewer pneumonia cases (OR, 0.53; 95% CI, 0.44-0.64), decreased length of hospital stay (ratio, 0.81; 95% CI, 0.79-0.82), and lower cost of care (ratio, 0.68; 95% CI, 0.67-0.69). There was no difference in the rate of readmission in regardless of the type of ventilation provided.

More from this author: Cigarette smoking remains a leading cause of preventable medical problems, Beta-lactam monotherapy may be inferior to combination therapy in pneumonia, Percutaneous intervention outcomes for STEMI similar for women and men, Mechanical aortic valve replacement linked with increased early mortality, Proton pump inhibitor boluses as effective as infusions in ulcer bleeds

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.   

Tags: copdventilation
Previous Post

USPSTF finds insufficient evidence for thyroid screening

Next Post

Scripted mental practice improves advanced laparoscopic surgery performance

RelatedReports

AI-read breathing tests collage: an older woman in a cardigan, a teal breathing loop on graph paper and a mouthpiece tube
Artificial Intelligence

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

May 12, 2026
Poverty, preterm birth demonstrate additive effect on cognition
Imaging and Intervention

High-frequency oscillatory ventilation may reduce the incidence of bronchopulmonary dysplasia in neonatal respiratory distress syndrome

March 20, 2026
Graves' disease collage: an engraved butterfly-shaped thyroid gland, a calm eye, folded sunglasses and a blank pill bottle
Career Development

What Is the Cricothyroid Membrane and Why It Matters in Medicine

September 17, 2025
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital
Pharma

GSK and Hengrui Pharma Forge $500 Million China Collaboration, Including PDE3/4 Inhibitors

August 27, 2025
Next Post

Scripted mental practice improves advanced laparoscopic surgery performance

Study lends support for interferon-free treatment of hepatitis C

Maintenance opioids in drug users linked with lower rate of hepatitis C infection

7 tesla breast MRI may improve assessment of suspicious masses

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.